摘要
20世纪末分子靶向药物的出现无疑是内科肿瘤学发展中的里程碑,在一定程度上实现了肿瘤的个体化治疗,但亦有不能耐受的不良反应发生。文章就中医药对其进行有效干预进行分析,说明中医药在改善生存质量,实现带瘤生存方面的优势。并且在恶性肿瘤治疗中已占有重要地位。
Of the 20th century targeted molecular medicine is undoubtedly the emergence of medical oncology milestone in development,and to some extent,it realized the tumor individual therapy,but there is still intolerate adverse reaction.This article is to analyze the Chinese medicine effective interventions,prove the living quality of TCM inprovement,and realize the survival with tumor advantages.And in malignant tumor therapy it has occupies an important position.
出处
《辽宁中医药大学学报》
CAS
2012年第6期183-184,共2页
Journal of Liaoning University of Traditional Chinese Medicine
关键词
恶性肿瘤
靶向药物
中医药
malignant tumor
targeted drugs
Chinese medicine
